Development of a Modified Score System as Prediction Model for Successful Vaginal Birth After Cesarean Delivery.


Journal

Clinical and translational science
ISSN: 1752-8062
Titre abrégé: Clin Transl Sci
Pays: United States
ID NLM: 101474067

Informations de publication

Date de publication:
01 2019
Historique:
received: 13 08 2018
accepted: 06 11 2018
pubmed: 15 12 2018
medline: 24 3 2020
entrez: 15 12 2018
Statut: ppublish

Résumé

This study was designed to establish a modified prediction score system to improve the safety and success rate of vaginal birth after cesarean delivery (VBAC). We recruited 406 patients (between January 2012 and December 2016) and generated a modified score system in predicting the success rate of VBAC. All patients were required to sign informed consent forms. There were 87.2% of patients who had successful VBAC deliveries and 12.8% patients who had repeated cesarean sections. We conducted multivariable logistic regression and found seven variables that were associated with VBAC success, including previous primary indication of cesarean delivery (odds ratio (OR), 2.1; 95% confidence interval (CI), 1.4-3.0), previous vaginal birth history (OR, 2.5; 95% CI, 1.8-3.8), < 40 years of age (OR, 2.1; 95% CI, 1.2-3.3), < 20 kg weight gain (OR, 1.5; 95% CI, 1.2-2.3), no labor induction (OR, 1.9; 95% CI, 1.5-2.9), high score of pelvic/birth weight (OR, 1.4; 95% CI, 1.1-2.1), and Bishop score (OR, 1.3; 95% CI, 1.2-1.4). After adjustment for optimism, the area under the receiver operating characteristic curve (AUC-ROC) was 0.849 (95% CI, 0.78-0.89), and the modified VBAC score was positively correlated with the success rate of trial of labor after cesarean delivery (TOLAC). A valid and useful score system was established to predict VBAC success rate.

Identifiants

pubmed: 30548202
doi: 10.1111/cts.12603
pmc: PMC6342239
doi:

Types de publication

Journal Article Validation Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

53-57

Informations de copyright

© 2018 The Authors. Clinical and Translational Science published by Wiley Periodicals, Inc. on behalf of the American Society for Clinical Pharmacology and Therapeutics.

Références

Am J Obstet Gynecol. 1996 Jan;174(1 Pt 1):192-8
pubmed: 8572005
Obstet Gynecol. 1964 Aug;24:266-8
pubmed: 14199536
Am J Obstet Gynecol. 2007 May;196(5):e22-3
pubmed: 17466668
Int J Womens Health. 2017 Feb 17;9:81-88
pubmed: 28255256
Am J Perinatol. 2011 Apr;28(4):293-8
pubmed: 21225561
N Engl J Med. 1996 Sep 5;335(10):689-95
pubmed: 8703167
Semin Perinatol. 2010 Aug;34(4):249-57
pubmed: 20654775
Obstet Gynecol. 2007 Apr;109(4):800-5
pubmed: 17400839
Obstet Gynecol. 2006 Jun;107(6):1226-32
pubmed: 16738145
Am J Obstet Gynecol. 1992 Jun;166(6 Pt 1):1811-5; discussion 1815-9
pubmed: 1615990
Obstet Gynecol. 1997 Dec;90(6):907-10
pubmed: 9397100
Am J Obstet Gynecol. 2005 Apr;192(4):1223-8; discussion 1228-9
pubmed: 15846208
Am J Perinatol. 2004 Nov;21(8):447-53
pubmed: 15580540
Am J Perinatol. 2009 Nov;26(10):693-701
pubmed: 19813165
Obstet Gynecol. 2007 Apr;109(4):806-12
pubmed: 17400840
Obstet Gynecol. 2007 Feb;109(2 Pt 1):262-9
pubmed: 17267822
Obstet Gynecol Surv. 2008 Aug;63(8):538-45
pubmed: 18631410
PLoS Med. 2005 Sep;2(9):e252
pubmed: 16146414
Clin Perinatol. 2011 Jun;38(2):179-92
pubmed: 21645788
N Engl J Med. 2004 Dec 16;351(25):2581-9
pubmed: 15598960

Auteurs

Yan-Ping Xing (YP)

The Second Department of Obstetrics, Cangzhou Central Hospital, Cangzhou, Yunhe District, Hebei Province, China.

Xin-Ying Qi (XY)

The Second Department of Obstetrics, Cangzhou Central Hospital, Cangzhou, Yunhe District, Hebei Province, China.

Xue-Zhen Wang (XZ)

The Second Department of Obstetrics, Cangzhou Central Hospital, Cangzhou, Yunhe District, Hebei Province, China.

Feng-Zhen Yang (FZ)

The Second Department of Obstetrics, Cangzhou Central Hospital, Cangzhou, Yunhe District, Hebei Province, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH